News - News - MicroPort® CardioFlow

News

Always Share with You
Every Bit of Our Progress

News

2018.12.11

First Patient Enrollment Was Successfully Completed for the Pre-market Clinical Research in Europe on VitaFlow^® II Transcatheter Aortic Valve and Retrievable Delivery System of MicroPort^® CardioFlow

Read More
2018.08.11

VitaFlow^® Has Been Admitted into the “Green Path”

Read More
2018.03.22

MicroPort^® CardioFlow Releases One-year Clinical Outcome of VitaFlow^®

Suzhou, China – From March 22 to March 25, MicroPort® Shanghai CardioFlow Medtech Co., Ltd. ("MicroPort® CardioFlow"), a wholly owned subsidiary of Shanghai MicroPort® Medical (Group) Co., Ltd. ("MicroPort®"), attended CIT 2018 and released the one-year clinical outcome of VitaFlow® Transcatheter Aortic Valve and Delivery System ("VitaFlow®").

Read More
2017.08.22

MicroPort^® CardioFlow Brings in Strategic Investors – China Renaissance, CICC and HuaTai Securities

Shanghai, China – On August 22, MicroPort Shanghai CardioFlow Medtech Co., Ltd. ("MicroPort®CardioFlow"), a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®"), entered into financing agreements at a consideration of RMB430million and achieved a valuation of RMB2.1 billion after this round of financing.

Read More
2017.01.04

Microport^® CardioFlow Completes Patient Enrollment of VitaFlow^® Pre-market Clinical Trial

Shanghai, China - MicroPort® CardioFlow has recently completed the patient enrollment of the pre-market clinical trial of its self-developed VitaFlow® Transcatheter Aortic Valve and Delivery System ("VitaFlow®"), which is three months prior to the scheduled completion date. The clinical trial is a prospective, multi-center trial, aiming at assessing the safety and efficacyof VitaFlow® in the treatment of severe aortic stenosis. The clinical trial was organized by Professor Junbo Ge, an academician of Chinese Society of Sciences and a renowned cardiologist. Zhongshan Hospital of Fudan University, led eleven domestic hospitals to complete the clinical trial.

Read More

<11 12 13 14 15 16 >

Privacy settings

This website may store cookies on your browser. Cookies are mostly used to make the website work asyou expect it to. No cookie will directly identify you, but it can give you a more personalized browsingexperience.

CardioFlow Medtech respects your privacy rights, so you can block some types of cookies. Technically non-essentialcookies and tracking mechanisms, that enable us to provide you with customized offers (marketingcookies), are only used if you have given prior consent to such use.

Strictly necessary cookies

Consent to marketing cookies

By clicking "Save", only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.

TOP

互联网药品信息服务资格证书编号：（沪）-非经营性 - 2024 - 0135

“MicroPort CardioFlow”及“ are registered trademarks of MicroPort CardioFlow Medtech Corporation.